AU Patent

AU2002315389A1 — Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof

Assigned to Ariad Pharmaceuticals Inc · Expires 2003-01-08 · 23y expired

What this patent protects

Patent listed against acalabrutinib-maleate.

Drugs covered by this patent

acalabrutinib-maleate (ACALABRUTINIB MALEATE)

Patent Metadata

Patent number: AU2002315389A1
Jurisdiction: AU
Classification: —
Expires: 2003-01-08
Drug substance claim: No
Drug product claim: No
Assignee: Ariad Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.